LUV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Southwest Airlines Co (LUV) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows positive financial growth and some analyst upgrades, the technical indicators are neutral to bearish, hedge funds are selling, and there are no strong proprietary trading signals. The options data suggests a bullish sentiment, but the overall market sentiment and recent news events do not provide a compelling reason to invest immediately.
The MACD is negatively expanding, indicating bearish momentum. The RSI is neutral at 47.034, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 49.906), with resistance at 52.088. Overall, the technical indicators suggest a neutral to bearish outlook.
Financial performance in Q4 2025 showed strong growth, with revenue up 7.39% YoY, net income up 23.75% YoY, and EPS up 36.59% YoY.
Analysts have upgraded price targets recently, with UBS raising its target to $73 and BMO Capital upgrading the stock to Outperform with a target of $57.
Initiatives like assigned seating and extra legroom are expected to drive incremental earnings growth by fiscal 2027.
Hedge funds are selling, with a significant 203.52% increase in selling activity last quarter.
Recent news highlights operational disruptions due to weather and geopolitical events, which could impact short-term performance.
Technical indicators are neutral to bearish, with no clear upward momentum.
In Q4 2025, Southwest Airlines reported revenue of $7.44 billion, up 7.39% YoY. Net income increased to $323 million, up 23.75% YoY, and EPS rose to $0.56, up 36.59% YoY. Gross margin improved slightly to 69.85%. These results indicate strong financial growth and operational efficiency.
Recent analyst ratings are mixed but leaning positive. UBS upgraded the stock to Buy with a price target of $73, citing potential earnings growth from new initiatives. BMO Capital also upgraded the stock to Outperform with a target of $57.50. However, some firms like Goldman Sachs and BofA remain skeptical, maintaining Sell and Underperform ratings, respectively, citing execution risks and valuation concerns.
